Payload Information
General Information of This Payload
| Payload ID | PAY0FROFP |
|||||
|---|---|---|---|---|---|---|
| Name | CL202203715A1 P43 |
|||||
| Synonyms |
CL202203715A1 P43
Click to Show/Hide
|
|||||
| Structure |
|
|||||
| Formula | C38H61N5O8S2 |
|||||
| Isosmiles | CCCCCCN(C(C[C@@H](C)CC)=O)[C@@H](C(C)C)C[C@@H](OC(C)=O)C1=NC(C(NS(C2=CC=C(O)C=C2)(=O)=O)=O)=CS1.CN3CCCC[C@@H]3C(NC)=O |
|||||
| InChI |
InChI=1S/C30H45N3O7S2.C8H16N2O/c1-7-9-10-11-16-33(28(36)17-21(5)8-2)26(20(3)4)18-27(40-22(6)34)30-31-25(19-41-30)29(37)32-42(38,39)24-14-12-23(35)13-15-24;1-9-8(11)7-5-3-4-6-10(7)2/h12-15,19-21,26-27,35H,7-11,16-18H2,1-6H3,(H,32,37);7H,3-6H2,1-2H3,(H,9,11)/t21-,26+,27+;7-/m01/s1
|
|||||
| InChIKey |
ZMJKNYQCUGOJFV-MBDSSUBPSA-N
|
|||||
| Pharmaceutical Properties | Molecule Weight |
780.067 |
Polar area |
175.31 |
||
Complexity |
1497.588452 |
xlogp Value |
6.0481 |
|||
Heavy Count |
53 |
Rot Bonds |
18 |
|||
Hbond acc |
11 |
Hbond Donor |
3 |
|||
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
TRSQ-ZP3A-LP22 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
0.376 nM
|
Positive HER2 expression (HER2+++/++) | ||
| Method Description |
The anti-proliferation test was carried out with SK-BR-3 human breast cancer cell line. Cells were grown in McCoy's 5a medium supplemented with 27% FBS,penicillin/streptomycin and L-glutamine.
|
||||
| In Vitro Model | Breast adenocarcinoma | SK-BR-3 cells | CVCL_0033 | ||
CTRL-ZP3A-LP22 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
461.721 nM
|
Positive HER2 expression (HER2+++/++) | ||
| Method Description |
The anti-proliferation test was carried out with SK-BR-3 human breast cancer cell line. Cells were grown in McCoy's 5a medium supplemented with 28% FBS,penicillin/streptomycin and L-glutamine.
|
||||
| In Vitro Model | Breast adenocarcinoma | SK-BR-3 cells | CVCL_0033 | ||